Cabioglu, N. Et Al. 2024. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer. Cancers , vol.16, no.13 .

Cabioglu, N., Onder, S., Karatay, H., Bayram, A., Oner, G., Tukenmez, M., ... Muslumanoglu, M.(2024). New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer. Cancers , vol.16, no.13.

Cabioglu, Neslihan Et Al. "New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer," Cancers , vol.16, no.13, 2024

Cabioglu, Neslihan Et Al. "New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer." Cancers , vol.16, no.13, 2024

Cabioglu, N. Et Al. (2024) . "New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer." Cancers , vol.16, no.13.

@article{article, author={Neslihan CABIOĞLU Et Al. }, title={New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer}, journal={Cancers}, year=2024}